NCT01446991 Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy Status COMPLETED Phase PHASE2
NCT01445054 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer Status TERMINATED Phase EARLY_PHASE1
NCT01444820 Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia Status COMPLETED Phase N/A
NCT01441687 Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome Status ACTIVE_NOT_RECRUITING Phase NA
NCT01441089 Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis Status RECRUITING Phase N/A
NCT01440855 Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting Status COMPLETED Phase NA
NCT01439542 FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer Status TERMINATED Phase PHASE2
NCT01437085 A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant Status UNKNOWN Phase N/A
NCT01436968 Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01436214 Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01434342 Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients Status COMPLETED Phase EARLY_PHASE1
NCT01434290 Radiation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT01431391 Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT01429064 Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001 Status COMPLETED Phase PHASE2
NCT01428869 Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer Status COMPLETED Phase N/A
NCT01424930 A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01420861 GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer Status TERMINATED Phase PHASE2